Newsroom
Stay up-to date with the latest news on healthcare
-
Adults With Cirrhosis in the ED: Trends From 2008 to 2022on September 13, 2024
Adults with cirrhosis made four times more ED visits and had nearly double the post-ED 90-day […]
-
High-Dose Prescription Amphetamine Tied to Psychosis Riskon September 12, 2024
A study has found a significantly increased risk of new-onset psychosis with use of high-dose […]
-
Addressing a ‘critical shortage’ of African public health researcherson September 12, 2024
Harvard Chan School researchers are working with African partners to enhance adolescent health […]
-
Elizabeth DeLucia starts as vice dean for development and alumni relationson September 12, 2024
Elizabeth "Liz" DeLucia brings deep leadership experience in fundraising and strategic planning to […]
-
The microbiome is worlds within worldson September 12, 2024
Wendy Garrett. Irene Heinz Given Professor of Immunology and Infectious Diseases, talks about one […]
-
Francisco Ruiz is bringing his truth to national HIV/AIDS policyon September 12, 2024
Francisco Ruiz, DrPH ’25, is drawing on his lived experiences in his work on national HIV/AIDS […]
-
CDC’s Mandy Cohen on COVID lessons and restoring trust in public healthon September 12, 2024
Mandy Cohen discusses looming health threats, lessons learned from COVID-19, and why public health […]
-
Student balances patient care and classwork in MPH-EPI programon September 12, 2024
Nasim Motayar, MPH ’25, reflects on her experiences in the hybrid MPH-EPI program.
-
Three lessons from a career dedicated to health equityon September 12, 2024
Shirley Sylvester, MPH ’06, shares lessons from a career dedicated to health equity.
-
Q&A with Dean Andrea Baccarelli on his deanship, emerging vision for Harvard Chan Schoolon September 12, 2024
Dean Andrea Baccarelli discusses the early months of his deanship and offered a glimpse into areas […]
-
Baveno VI Criteria May Cut Need for Endoscopies in Cirrhosison September 12, 2024
The Baveno VI criteria could be considered for widespread implementation due to favorable safety […]
-
The next pandemic: not if, but whenon September 12, 2024
As new cases of bird flu and other infectious diseases continue to raise concern, Harvard T.H. Chan […]
-
'Remarkable' Weight Loss With Novel Oral Combo in Phase 1on September 12, 2024
Amycretin, a dual pathway, oral weight loss drug, was found to be safe and tolerable in a phase 1 […]
-
Meet the winners of the 2024 Alumni Awardson September 12, 2024
Six Harvard T.H. Chan School of Public Health alumni are being honored for their outstanding […]
-
GI-Targeted Bitter Hop Extract Curbs Hunger, Food Cravingson September 12, 2024
A gastrointestinal-targeted bitter hop extract reduced hunger and food cravings, as well as […]
-
Montana Hospital to Pay $10.8M to Settle Cancer Fraud Suiton September 12, 2024
Separately, oncologist Thomas Weiner, a former employee, also faces a civil suit, which alleges he […]
-
Tusa Rav Not Better Than Docetaxel for NSCLCon September 12, 2024
A phase 3 study of the novel antibody-drug conjugate tusamitamab ravtansine in advanced nonsquamous […]
-
Is Minimal Access Nipple-Sparing Mastectomy a Safer Option?on September 12, 2024
The incidence of postoperative complications was similar in patients undergoing minimal access and […]
-
Eating Fruits and Oats Ups Type 1 Diabetes Risk in Some Kidson September 12, 2024
A higher consumption of fruits, oats, or rye upped the risk for T1D in children with genetic […]
-
Treatment Options in MCL: What Are the Best Practices?on September 12, 2024
Good options exist in the frontline setting, but relapsed/refractory cases remain a challenge. […]
-
Icodec + Semaglutide Combo Shows Benefit in Type 2 Diabeteson September 12, 2024
Combination may offer a substitute to basal-bolus insulin in people with type 2 diabetes […]
-
Early vs Late Fast Window: Is One More Effective?on September 12, 2024
Restricting eating to an 8-hour window improves blood glucose no matter whether the eating window […]
-
Belimumab Hits Newer Remission, Low Disease Activity Metricson September 12, 2024
Compared with placebo plus standard therapy, belimumab plus standard therapy led to higher rates of […]
-
Expert Warns of AI Pitfalls in Dermatologyon September 12, 2024
"These models are not appropriate to use for patient care," Roxana Daneshjou, MD, PhD, said. […]
-
AI Doubles Cardiomyopathy Detection in Pregnant Womenon September 12, 2024
The study highlighted the potential of AI-guided screening to improve the diagnosis of […]
-
No Benefit to Anticoagulation After STEMI Revascularizationon September 12, 2024
Randomized trial data showed no difference in ischemic events or major bleeding with prolonged vs […]
-
Long-COVID Patients Show Abnormal Lung Perfusion Despite Normal CTson September 12, 2024
A study found abnormal lung perfusion in long-COVID patients with normal CT scans, highlighting […]
-
FDA Investigates Tampons for Potential Lead and Metal Riskson September 12, 2024
The FDA has launched an investigation of the potential exposure to heavy metals when using tampons, […]
-
Ultra-Processed Doesn't Always Mean Bad — Here's How to Tellon September 12, 2024
You may have been warned that ultra-processed foods can wreak havoc on your health. But not all of […]
-
Hormone Therapy Can Benefit Women Into Their 80son September 12, 2024
Hormone therapy (HT) can help women manage menopause symptoms into their 80s, and the reasons are […]